Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
4
×
boston blog main
boston top stories
national top stories
san diego blog main
san diego top stories
seattle blog main
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
deals
detroit blog main
detroit top stories
drug prices
fda
gilead sciences
indiana blog main
indiana top stories
national
new york blog main
new york top stories
president trump
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle top stories
sickle cell disease
startups
svb leerink
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acquisition
adverum biotechnologies
albert bourla
What
company
acquisitions
administration
albert
awaited
based
biggest
bio
bourla
canada
canadian
carlsmed
ceo
cf
cheaper
costly
countries
crisis
crispr
cystic
department
developer
developing
diego
drug
drugs
excludes
fibrosis
floats
force
future
health
helped
house
imaging
implants
import
imports
jeff
leiden
Language
unknown
4
×
Current search:
unknown
×
biotech
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company